טוען...
Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy
BACKGROUND: Maternal risks of betamethasone have been rarely reported. CASE: At 36 weeks' gestation, a previously healthy 23-year-old gravida with fetal intrauterine growth restriction was admitted to the hospital for steroid administration. Twenty-six hours after the first dose of betamethason...
שמור ב:
| הוצא לאור ב: | Case Rep Obstet Gynecol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6815974/ https://ncbi.nlm.nih.gov/pubmed/31737387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6873057 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|